Yet, the caveat is that tPA is subject to a narrow therapeutic window in stroke; and the protein being able to permeate the blood–brain barrier, may promote intracerebral haemorrhage, and induce excitotoxicity damage [12, 79, 174]. This evidence concerns the gene PLAT and stroke disorder.